OverviewChartNewsTraderScreen

UC DIS.CERT. 12/24 BRM/  DE000HD1NM77  /

gettex
28/06/2024  21:47:13 Chg.-0.020 Bid21:59:47 Ask21:59:47 Underlying Strike price Expiration date Option type
34.260EUR -0.06% 34.250
Bid Size: 2,000		 34.260
Ask Size: 2,000		 BRISTOL-MYERS SQUIBB... - - 31/12/2024 Call
GlobeNewswire 26/06 Intellia Therapeutics Announces CFO Transition
GlobeNewswire 19/06 Data From Lexicon’s RELIEF-DPN 1 Phase 2 Study of LX9211 Published Today in Diabetes Care, a Peer-Re...
GlobeNewswire 19/06 CSE is hosting in New York City the Sustainability & ESG Leadership Summit
GlobeNewswire 18/06 CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Confere...
GlobeNewswire 17/06 CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
GlobeNewswire 17/06 Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increa...
GlobeNewswire 17/06 Arvinas Announces Promotions of Ian Taylor, Ph.D. to President of Research and Development and Angel...
GlobeNewswire 14/06 Findings on the Burdens of Diabetic Peripheral Neuropathic Pain (DPNP) Among Three Lexicon-Sponsored...
GlobeNewswire 12/06 Crossject appoints Dan Chiche, MD as Chief Medical Officer North America
GlobeNewswire 11/06 Vera Therapeutics Appoints Christy J. Oliger to Board of Directors
GlobeNewswire 11/06 Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retire...
GlobeNewswire 11/06 Allyx Therapeutics Announces First Alzheimer’s Disease Patient Treated with Lead Compound ALX-001
GlobeNewswire 10/06 RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships
GlobeNewswire 10/06 C4 Therapeutics Appoints Ron Cooper as Chairman of the Board of Directors
GlobeNewswire 31/05 Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting P...
GlobeNewswire 30/05 Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retire...
GlobeNewswire 24/05 Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board
GlobeNewswire 23/05 Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retire...
GlobeNewswire 23/05 Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...
GlobeNewswire 22/05 CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 22/05 Anavex Life Sciences Announces Expansion of Leadership Team
GlobeNewswire 16/05 CytomX Therapeutics Announces New Employment Inducement Grants
GlobeNewswire 15/05 Lantheus Announces Executive Appointments to Accelerate Innovation
GlobeNewswire 14/05 Firefly Neuroscience, an AI-Driven Brain Health Company, Appoints Healthcare-Industry Executive, Dav...
GlobeNewswire 14/05 Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Adv...